| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Operating Officer
1 company
Shlevin Harold H. is a Director at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 1 buy and 22 sells.
Estimated insider holdings value: $14K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | GALT Galectin Therapeutics Inc | Director | Sale+OE | 24,499 | $7.04 | $172,423.96 | -58.0% | -51.3% | - | |
| Dec 15, 2025 | GALT Galectin Therapeutics Inc | Director | Sale+OE | 28,210 | $6.28 | $177,208.38 | -55.7% | -51.2% | - | |
| Dec 9, 2025 | GALT Galectin Therapeutics Inc | Director | Sale+OE | 175,790 | $6.00 | $1,055,311.14 | -66.2% | -43.7% | - | |
| Dec 30, 2024 | GALT Galectin Therapeutics Inc | Director | Buy | 6,500 | $1.16 | $7,540.00 | +74.7% | +10.9% | +270.9% | |
| Jun 13, 2018 | GALT Galectin Therapeutics Inc | Chief Operating Officer | Sale+OE | 43,698 | $7.41 | $323,986.15 | -89.0% | - | - | |
| Jun 11, 2018 | GALT Galectin Therapeutics Inc | Chief Operating Officer | Sale+OE | 115,054 | $5.84 | $671,987.54 | -71.0% | - | - | |
| Jun 7, 2018 | GALT Galectin Therapeutics Inc | Chief Operating Officer | Sale+OE | 109,969 | $5.20 | $572,020.51 | -50.5% | - | - | |
| Jun 5, 2018 | GALT Galectin Therapeutics Inc | Chief Operating Officer | Sale+OE | 20,831 | $5.15 | $107,356.26 | -16.2% | - | - | |
| Jun 1, 2018 | GALT Galectin Therapeutics Inc | Chief Operating Officer | Sale+OE | 119,200 | $5.06 | $602,920.00 | -52.5% | - | - |